Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

JUN Specifies the Local Differentiation and Maintenance of Pro-tumoral Monocyte-Derived Macrophages.

Cancer research·2026
Same author

A new approach for identifying innate immune defects.

Diagnosis (Berlin, Germany)·2024
Same author

[The dance between Brucella and hematopoietic stem cells].

Medecine sciences : M/S·2023
Same author

M-CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation.

EMBO molecular medicine·2023
Same author

Isolation, Ex Vivo Expansion, and Lentiviral Transduction of Alveolar Macrophages.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

CD150-dependent hematopoietic stem cell sensing of Brucella instructs myeloid commitment.

The Journal of experimental medicine·2023

Related Experiment Video

Updated: Jun 5, 2026

Generation of Genetically Modified Organotypic Skin Cultures Using Devitalized Human Dermis
09:16

Generation of Genetically Modified Organotypic Skin Cultures Using Devitalized Human Dermis

Published on: December 14, 2015

Creating a blood line from human skin.

Michael H Sieweke1

  • 1Centre d'Immunologie de Marseille-Luminy, Université Aix-Marseille, Campus de Luminy, Case 906, 13288 Marseille Cedex 09, France. sieweke@ciml.univ-mrs.fr

Genome Biology
|December 22, 2010
PubMed
Summary

Researchers directly converted human fibroblasts into blood cell progenitors. This method bypasses the need for pluripotent stem cells, offering therapeutic potential.

Area of Science:

  • Stem cell biology
  • Cellular reprogramming
  • Hematopoiesis

Background:

  • Pluripotent stem cells (PSCs) offer therapeutic potential but raise safety concerns.
  • Direct lineage conversion bypasses the need for a pluripotent intermediate.

Purpose of the Study:

  • To generate blood cell progenitors directly from human fibroblasts.
  • To evaluate the therapeutic potential of these directly converted progenitors.

Main Methods:

  • Direct lineage conversion of human fibroblasts.
  • Induction of hematopoietic progenitor markers.

Main Results:

  • Successful generation of blood cell progenitors from fibroblasts.
  • Demonstrated therapeutic potential of the generated progenitors.

More Related Videos

Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells
09:54

Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells

Published on: April 18, 2019

Generation of Self-assembled Vascularized Human Skin Equivalents
09:04

Generation of Self-assembled Vascularized Human Skin Equivalents

Published on: February 12, 2021

Related Experiment Videos

Last Updated: Jun 5, 2026

Generation of Genetically Modified Organotypic Skin Cultures Using Devitalized Human Dermis
09:16

Generation of Genetically Modified Organotypic Skin Cultures Using Devitalized Human Dermis

Published on: December 14, 2015

Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells
09:54

Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells

Published on: April 18, 2019

Generation of Self-assembled Vascularized Human Skin Equivalents
09:04

Generation of Self-assembled Vascularized Human Skin Equivalents

Published on: February 12, 2021

Conclusions:

  • Direct lineage conversion is a viable strategy for generating blood cell progenitors.
  • This approach avoids risks associated with pluripotent stem cells.